222 related articles for article (PubMed ID: 32113125)
1. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents.
Liu Y; Wu Y; Sun L; Gu Y; Hu L
Eur J Med Chem; 2020 Apr; 191():112181. PubMed ID: 32113125
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluations of the antiproliferative activity and aqueous solubility of novel carbazole sulfonamide derivatives as antitumor agents.
Sun L; Wang C; Hu X; Wu Y; Jiang Z; Li Z; Chen X; Hu L
Bioorg Chem; 2020 Jun; 99():103766. PubMed ID: 32247110
[TBL] [Abstract][Full Text] [Related]
3. Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility.
Sun L; Wu Y; Liu Y; Chen X; Hu L
Bioorg Med Chem Lett; 2017 Jan; 27(2):261-265. PubMed ID: 27919655
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship study of new carbazole sulfonamide derivatives as anticancer agents with dual-target mechanism.
Liu Y; Zhang J; Tian J; Wang C; Wang T; Gong J; Hu L
Eur J Med Chem; 2024 Jul; 273():116509. PubMed ID: 38781920
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
[TBL] [Abstract][Full Text] [Related]
6. Selective and effective anticancer agents: Synthesis, biological evaluation and structure-activity relationships of novel carbazole derivatives.
Huang W; Gao Z; Zhang Z; Fang W; Wang Z; Wan Z; Shi L; Wang K; Ke S
Bioorg Chem; 2021 Aug; 113():104991. PubMed ID: 34051416
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors.
Hu L; Li ZR; Li Y; Qu J; Ling YH; Jiang JD; Boykin DW
J Med Chem; 2006 Oct; 49(21):6273-82. PubMed ID: 17034133
[TBL] [Abstract][Full Text] [Related]
8. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.
Hu L; Li ZR; Wang YM; Wu Y; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2007 Mar; 17(5):1193-6. PubMed ID: 17197178
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
Cheng C; Yun F; He J; Ullah S; Yuan Q
Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
[TBL] [Abstract][Full Text] [Related]
10. Combination of 2-methoxy-3-phenylsulfonylaminobenzamide and 2-aminobenzothiazole to discover novel anticancer agents.
Li H; Wang XM; Wang J; Shao T; Li YP; Mei QB; Lu SM; Zhang SQ
Bioorg Med Chem; 2014 Jul; 22(14):3739-48. PubMed ID: 24878359
[TBL] [Abstract][Full Text] [Related]
11. Biological potential of carbazole derivatives.
Głuszyńska A
Eur J Med Chem; 2015 Apr; 94():405-26. PubMed ID: 25794500
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
[TBL] [Abstract][Full Text] [Related]
14. Alkylsulfonamide-containing quinazoline derivatives as potent and orally bioavailable PI3Ks inhibitors.
Hei YY; Zhang SQ; Feng Y; Wang J; Duan W; Zhang H; Mao S; Sun H; Xin M
Bioorg Med Chem; 2019 Oct; 27(20):114930. PubMed ID: 31176568
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents.
Li L; Quan D; Chen J; Ding J; Zhao J; Lv L; Chen J
Eur J Med Chem; 2019 Dec; 184():111732. PubMed ID: 31610372
[TBL] [Abstract][Full Text] [Related]
16. Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity.
Wang J; Li T; Zhao T; Wu T; Liu C; Ding H; Li Z; Bian J
Eur J Med Chem; 2019 Sep; 178():782-801. PubMed ID: 31238183
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.
Chen S; Bi K; Wu S; Li Y; Huang Y; Sheng C; Dong G
Eur J Med Chem; 2021 Aug; 220():113544. PubMed ID: 34052678
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
[TBL] [Abstract][Full Text] [Related]
19. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.
Niu F; Liu Y; Jing Z; Han G; Sun L; Yan L; Zhou L; Wu Y; Xu Y; Hu L; Zhao X
Cancer Lett; 2018 Apr; 420():60-71. PubMed ID: 29408653
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I.
Caruso A; Chimento A; El-Kashef H; Lancelot JC; Panno A; Pezzi V; Saturnino C; Sinicropi MS; Sirianni R; Rault S
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):609-13. PubMed ID: 21883039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
